Myeloma Therapy

Pursuing the Plasma Cell

  • Sagar Lonial

Part of the Contemporary Hematology book series (CH)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Biologic Consideration and Myeloma

    1. Leonard T. Heffner
      Pages 3-7
    2. Amelia A. Langston, Dixil Francis
      Pages 9-22
    3. Wee Joo Chng, Peter Leif Bergsagel
      Pages 41-56
    4. Esteban Braggio, Michael Sebag, Rafael Fonseca
      Pages 57-76
  3. Historical and Cytotoxic Agent-Based Therapies for Myeloma

    1. Jonathan L. Kaufman, Ronald Mihelic, Sagar Lonial
      Pages 91-98
    2. Bringhen Sara, Palumbo Antonio
      Pages 99-112
    3. Sikander Ailawadhi, Asher Chanan-Khan
      Pages 113-121
  4. Immune-Based Therapies

    1. Fengrong Wang, Edmund K. Waller
      Pages 125-142
    2. Madhav V. Dhodapkar
      Pages 143-166
    3. Nikhil C. Munshi, Yu-Tzu Tai
      Pages 167-202
  5. Existing Novel Agents

    1. Francis K. Buadi, S. Vincent Rajkumar
      Pages 229-237
    2. Paul G. Richardson, Constantine S. Mitsiades, Robert Schlossman, Teru Hideshima, Irene Ghobrial, Nikhil C. Munshi et al.
      Pages 239-252
    3. San J. F. Miguel, M. V. Mateos
      Pages 253-263
    4. Sheeba K. Thomas, Tiffany A. Richards, Donna M. Weber
      Pages 265-277
  6. Current and Future Targets

    1. Constantine S. Mitsiades, Teru Hideshima, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson
      Pages 291-308
    2. R. Donald Harvey, Jeannine Silberman, Sagar Lonial
      Pages 309-322
    3. Patrick Frost, Alan Lichtenstein
      Pages 323-330
    4. Yun Dai, Steven Grant
      Pages 331-363
    5. Victor Hugo Jiménez-Zepeda, A. Keith Stewart
      Pages 365-378
    6. Dharminder Chauhan, Dharminder Ajita, Dharminder Singh, Kenneth Anderson
      Pages 421-432
  7. Supportive Care

  8. Other Plasma Cell Disorders

    1. Lijo Simpson, Morie Gertz
      Pages 519-550
    2. Vaishali Sanchorawala
      Pages 551-569
    3. Robert A. Kyle, S. Vincent Rajkumar
      Pages 625-649
  9. Back Matter
    Pages 651-663

About this book


Therapeutic options for patients with myeloma have radically changed over the past ten years. Myeloma Therapy: Pursuing the Plasma Cell provides updated various treatment options for patients with myeloma, with focus on the emerging and speculative aspects of myeloma therapy. Written by clearly acknowledged leaders in the field of myeloma therapy and research, Myeloma Therapy: Pursuing the Plasma Cell presents significant material on the biology and potential agents used to address specific signaling pathways, all of which are critical to myeloma biology and therapy. State of the art information from many of the leaders in the plasma cell disorders world includes disease pathogenesis and biology, chemotherapy based approaches, immune based therapies, currently approved novel agents, developing targets, supportive care, and other plasma cell disorders. Myeloma Therapy: Pursuing the Plasma Cell is a comprehensive collection and tremendous source in this time of rapid change in clinical and preclinical disease knowledge.


Angst Autologous Bone Marrow Bortezomib Chemotherapy Hematology Lenalidomide Myeloma Plasma cell Staging Thalidomide Therapeutic classification

Editors and affiliations

  • Sagar Lonial
    • 1
  1. 1.Winship Cancer InstituteEmory UniversityAtlantaUSA

Bibliographic information